{"id":"https://openalex.org/W2806011204","doi":"https://doi.org/10.1212/wnl.90.15_supplement.p5.273","title":"An Analysis of the Accuracy and Utility of Automated Kit (AK) Assays in Quantifying Thyroid Hormone Levels in Patients Taking Eslicarbazepine Acetate (ESL) (P5.273)","display_name":"An Analysis of the Accuracy and Utility of Automated Kit (AK) Assays in Quantifying Thyroid Hormone Levels in Patients Taking Eslicarbazepine Acetate (ESL) (P5.273)","publication_year":2018,"publication_date":"2018-04-10","ids":{"openalex":"https://openalex.org/W2806011204","doi":"https://doi.org/10.1212/wnl.90.15_supplement.p5.273","mag":"2806011204"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.90.15_supplement.p5.273","doi":"https://doi.org/10.1212/wnl.90.15_supplement.p5.273","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.90.15_supplement.p5.273","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"John Eddy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Eddy","raw_affiliation_strings":["Sunovion Pharmaceuticals Inc. Marlborough MA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sunovion Pharmaceuticals Inc. Marlborough MA United States","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084941652","display_name":"Todd Grinnell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Todd Grinnell","raw_affiliation_strings":["Sunovion Pharmaceuticals Inc. Marlborough MA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sunovion Pharmaceuticals Inc. Marlborough MA United States","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058075739","display_name":"Yan Li","orcid":"https://orcid.org/0000-0003-2145-2869","observed_orcids":["https://orcid.org/0000-0003-2145-2869"]},"institutions":[{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yan Li","raw_affiliation_strings":["Sunovion Pharmaceuticals Inc. Marlborough MA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sunovion Pharmaceuticals Inc. Marlborough MA United States","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101974561","display_name":"David Cantu","orcid":"https://orcid.org/0000-0003-3174-0530","observed_orcids":["https://orcid.org/0000-0003-3174-0530"]},"institutions":[{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Cantu","raw_affiliation_strings":["Sunovion Pharmaceuticals Inc. Marlborough MA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sunovion Pharmaceuticals Inc. Marlborough MA United States","institution_ids":["https://openalex.org/I4210122020"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103238393","display_name":"David E. Blum","orcid":"https://orcid.org/0000-0002-1150-8331","observed_orcids":["https://orcid.org/0000-0002-1150-8331"]},"institutions":[{"id":"https://openalex.org/I4210122020","display_name":"Sunovion (United States)","ror":"https://ror.org/030zc7t66","country_code":"US","type":"company","lineage":["https://openalex.org/I4210122020"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Blum","raw_affiliation_strings":["Sunovion Pharmaceuticals Inc. Marlborough MA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sunovion Pharmaceuticals Inc. Marlborough MA United States","institution_ids":["https://openalex.org/I4210122020"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210122020"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.08588061,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"90","issue":"15_supplement","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11314","display_name":"Clinical Laboratory Practices and Quality Control","score":0.711899995803833,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11314","display_name":"Clinical Laboratory Practices and Quality Control","score":0.711899995803833,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10293","display_name":"Thyroid Disorders and Treatments","score":0.25760000944137573,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eslicarbazepine-acetate","display_name":"eslicarbazepine acetate","score":0.972000002861023},{"id":"https://openalex.org/keywords/thyroid-hormone-measurement","display_name":"thyroid hormone measurement","score":0.6330000162124634},{"id":"https://openalex.org/keywords/drug-metabolites","display_name":"drug metabolites","score":0.9150000214576721},{"id":"https://openalex.org/keywords/thyroid-function-tests","display_name":"thyroid function tests","score":0.5479999780654907},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.7799999713897705}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6366763710975647},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.5328023433685303},{"id":"https://openalex.org/C526584372","wikidata":"https://www.wikidata.org/wiki/Q16399","display_name":"Thyroid","level":2,"score":0.4967675805091858},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3843510150909424},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35861557722091675}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.90.15_supplement.p5.273","doi":"https://doi.org/10.1212/wnl.90.15_supplement.p5.273","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.90.15_supplement.p5.273","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2807164032","https://openalex.org/W2805395543","https://openalex.org/W4389441594","https://openalex.org/W2980842738","https://openalex.org/W2560685728","https://openalex.org/W3200086292","https://openalex.org/W2131838439","https://openalex.org/W2105460680","https://openalex.org/W1988758953","https://openalex.org/W2764203347"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"assess":[2],"whether":[3],"ESL":[4,16,44,47,72,88,112,215,249,270,291,295],"metabolites":[5,48,113,250,271],"interfere":[6],"with":[7,43,68,108,203,240,290,329,352,375,397,420],"thyroid":[8,60,275],"hormone":[9,61,145,276],"measurements":[10,32,62,182,194,221,226,256],"by":[11,63,130,156,195,232,280],"the":[12,64,131,157,196,233,281,285],"AK":[13,30,65,132,158,197,219,234,254,282],"assay.":[14,159,283],"Background:":[15],"is":[17],"a":[18,213,321,344,367,389,412],"once-daily":[19],"oral":[20],"antiepileptic":[21],"drug":[22],"for":[23,93,317,340,363,385,408],"partial-onset":[24],"(focal)":[25],"seizures.":[26],"In":[27],"previous":[28],"trials,":[29],"assay":[31,133,198,220,235,255,302],"of":[33,111,168,222,257],"free":[34,38,59],"thyroxine":[35],"(FT4)":[36],"and":[37,105,126,134,150,224,229,243,260,263],"triiodothyronine":[39],"(FT3)":[40],"were":[41,128,154,183,199,236,246,266,298],"lower":[42,58,286],"versus":[45],"placebo.":[46],"may":[49],"disrupt":[50],"protein":[51],"binding":[52],"in":[53,57,218,294],"serum":[54,83,99],"samples,":[55],"resulting":[56],"assay,":[66],"compared":[67],"samples":[69,84,100],"not":[70,252,273,299],"containing":[71],"metabolites.":[73],"Design/Methods:":[74],"Study":[75,304],"093\u2013451":[76],"comprised":[77],"two":[78],"parts.":[79],"Part-1":[80],"(n=31)":[81,97],"used":[82,98],"from":[85,101],"patients":[86],"receiving":[87],"\u22651200":[89],"mg":[90],"per":[91],"day":[92],"\u22656":[94],"weeks.":[95],"Part-2":[96],"healthy":[102],"volunteers":[103],"(age-":[104],"gender-matched)":[106],"spiked":[107,228],"different":[109],"concentrations":[110],"(low:":[114],"5.0\u03bcg/mL":[115],"eslicarbazepine,":[116],"0.5\u03bcg/mL":[117],"(R)-licarbazepine;":[118],"medium:":[119],"12.5\u03bcg/mL,":[120],"1.25\u03bcg/mL;":[121],"high:":[122],"20.0\u03bcg/mL,":[123],"2.0\u03bcg/mL).":[124],"FT4":[125,181,223],"FT3":[127,193],"measured":[129,155,279],"equilibrium":[135],"dialysis":[136],"(ED)":[137],"(a":[138],"gold-standard":[139],"physical":[140],"separation":[141],"technique).":[142],"Thyroid":[143],"stimulating":[144],"(TSH),":[146],"total":[147,151],"T4":[148],"(TT4),":[149],"T3":[152],"(TT3)":[153],"Data":[160],"are":[161],"reported":[162],"as":[163,278],"geometric":[164,169],"means":[165,170],"or":[166,174,326,349,372,394,417],"ratios":[167],"([AK":[171],"assay/ED":[172],"measurement]":[173],"[spiked":[175],"sample/non-spiked":[176],"sample":[177],"measurement]).":[178],"Results:":[179],"Part-1:":[180],"comparable":[184],"between":[185],"analytical":[186],"techniques":[187],"(ratio:":[188,205],"1.05,":[189],"90%":[190,207,244,264],"CI:":[191,208],"0.98\u20131.12).":[192],"slightly":[200,237],"higher":[201,238],"than":[202,239],"ED":[204,241],"1.15,":[206],"1.09\u20131.22).":[209],"Part-2:":[210],"there":[211],"was":[212],"small":[214],"metabolite-dependent":[216],"increase":[217],"FT3;":[225],"(in":[227],"non-spiked":[230],"samples)":[231],"(ratios":[242,262],"CIs":[245,265],"largely":[247],">1.0).":[248],"did":[251,272],"affect":[253],"TSH,":[258],"TT4,":[259],"TT3":[261],"all":[267],"~1.0).":[268],"Conclusions:":[269],"reduce":[274],"levels":[277,288],"Therefore,":[284],"FT4/FT3":[287],"observed":[289],"(versus":[292],"placebo)":[293],"clinical":[296],"trials":[297],"due":[300],"to":[301],"interference.":[303],"Supported":[305],"by:":[306],"Sunovion":[307,331,354,376,399,422],"Pharmaceuticals":[308,332,355,377,400,423],"Inc.":[309,333,356,378,401,424],"Disclosure:":[310],"Dr.":[311,334,357,379,402],"Eddy":[312],"has":[313,336,359,381,404],"received":[314,337,360,382,405],"personal":[315,338,361,383,406],"compensation":[316,339,362,384,407],"consulting,":[318,341,364,386,409],"serving":[319,342,365,387,410],"on":[320,343,366,388,411],"scientific":[322,345,368,390,413],"advisory":[323,346,369,391,414],"board,":[324,347,370,392,415],"speaking,":[325,348,371,393,416],"other":[327,350,373,395,418],"activities":[328,351,374,396,419],"Employment:":[330,353,398,421],"Grinnell":[335],"Li":[358],"Cantu":[380],"Blum":[403]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-06-13T00:00:00"}